Oracle (ORCL) Earnings Analysis
Oracle (ORCL) next reports earnings on 2026-09-08, consensus EPS 1.72 USD. Last quarter (2026-06-10) it beat with EPS 2.11 USD vs 1.96 USD est (+7.7%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E 21.19.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ORCL next report earnings?
| Next earnings date | 2026-09-08 |
|---|---|
| Consensus EPS estimate | 1.72 USD |
| Revenue estimate | 19.13B |
ORCL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-10 | 2.11 USD | 1.96 USD | +7.7% | Beat |
| 2026-03-10 | 1.79 USD | 1.7 USD | +5.3% | Beat |
| 2025-12-10 | 2.26 USD | 1.64 USD | +37.8% | Beat |
| 2025-09-09 | 1.47 USD | 1.48 USD | -0.7% | Miss |
| 2025-06-11 | 1.7 USD | 1.64 USD | +3.7% | Beat |
| 2025-03-10 | 1.47 USD | 1.49 USD | -1.3% | Miss |
| 2024-12-09 | 1.47 USD | 1.48 USD | -0.7% | Miss |
| 2024-09-09 | 1.39 USD | 1.33 USD | +4.5% | Beat |
Beat rate: 5/8 (63%) over reported quarters with consensus data.
ORCL valuation and analyst view
| Trailing P/E | 21.19 |
|---|---|
| Trailing EPS | 5.937 USD |
| Price / book | 8.52 |
| Dividend yield | 1.59% |
| Market cap | 364.34B |
| Analyst consensus | Buy (56 buy / 26 hold / 4 sell) |
| Avg price target | 252.38 USD |
Related research pages
Frequently asked questions
When is Oracle (ORCL)'s next earnings date?
Oracle is next scheduled to report on 2026-09-08, with a consensus EPS estimate of 1.72 USD and revenue estimate of 19.13B.
Did ORCL beat earnings last quarter?
In its 2026-06-10 report, ORCL posted EPS of 2.11 USD versus a 1.96 USD estimate — a beat of 7.7%.
What is ORCL's earnings track record?
Over the last 8 reported quarters with consensus data, ORCL beat estimates 5 times (63%).
What is ORCL's current P/E ratio and EPS?
ORCL trades at a trailing P/E of 21.19 on trailing EPS of 5.9371091035441275 USD.
What do analysts rate ORCL?
Analyst consensus is "Buy" across 86 ratings (0 strong buy, 56 buy, 26 hold, 4 sell, 0 strong sell). Average 12-month price target: 252.38 USD.